1. Home
  2. INTG vs CELU Comparison

INTG vs CELU Comparison

Compare INTG & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intergroup Corporation (The)

INTG

Intergroup Corporation (The)

HOLD

Current Price

$27.85

Market Cap

38.9M

Sector

Real Estate

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.30

Market Cap

34.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTG
CELU
Founded
1965
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
34.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
INTG
CELU
Price
$27.85
$1.30
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
17.1K
81.0K
Earning Date
02-13-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$65,385,000.00
$40,578,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
9.82
N/A
52 Week Low
$9.57
$1.00
52 Week High
$42.50
$4.35

Technical Indicators

Market Signals
Indicator
INTG
CELU
Relative Strength Index (RSI) 51.23 40.30
Support Level $25.00 $1.20
Resistance Level $28.40 $1.31
Average True Range (ATR) 1.92 0.12
MACD 0.32 0.02
Stochastic Oscillator 73.99 56.06

Price Performance

Historical Comparison
INTG
CELU

About INTG Intergroup Corporation (The)

The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: